These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 25003310)
1. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Tardy M; Dold M; Engel RR; Leucht S Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009396. PubMed ID: 25003310 [TBL] [Abstract][Full Text] [Related]
2. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. Tardy M; Huhn M; Kissling W; Engel RR; Leucht S Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009268. PubMed ID: 25007358 [TBL] [Abstract][Full Text] [Related]
3. Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Tardy M; Huhn M; Engel RR; Leucht S Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009230. PubMed ID: 25087165 [TBL] [Abstract][Full Text] [Related]
4. Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Tardy M; Huhn M; Engel RR; Leucht S Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD009369. PubMed ID: 25290157 [TBL] [Abstract][Full Text] [Related]
5. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Dold M; Samara MT; Li C; Tardy M; Leucht S Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299 [TBL] [Abstract][Full Text] [Related]
6. Maintenance treatment with antipsychotic drugs for schizophrenia. Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM; Leucht S Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008016. PubMed ID: 32840872 [TBL] [Abstract][Full Text] [Related]
13. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. Saha KB; Bo L; Zhao S; Xia J; Sampson S; Zaman RU Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010631. PubMed ID: 27045703 [TBL] [Abstract][Full Text] [Related]
14. Risperidone versus other atypical antipsychotics for schizophrenia. Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678 [TBL] [Abstract][Full Text] [Related]
15. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. Temmingh HS; Williams T; Siegfried N; Stein DJ Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909 [TBL] [Abstract][Full Text] [Related]
17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
18. Olanzapine versus other atypical antipsychotics for schizophrenia. Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348 [TBL] [Abstract][Full Text] [Related]
19. Wendan decoction (Traditional Chinese medicine) for schizophrenia. Deng H; Xu J Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012217. PubMed ID: 28657646 [TBL] [Abstract][Full Text] [Related]
20. Maintenance treatment with antipsychotic drugs for schizophrenia. Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM Cochrane Database Syst Rev; 2012 May; (5):CD008016. PubMed ID: 22592725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]